Jefferies raised its price target on Buy-rated Neurocrine Bio. (NASDAQ: NBIX) from $13 to $14 following Q4 results and 2013 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE